These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23296932)

  • 1. Large volume flow electroporation of mRNA: clinical scale process.
    Li L; Allen C; Shivakumar R; Peshwa MV
    Methods Mol Biol; 2013; 969():127-38. PubMed ID: 23296932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of chimeric antigen receptors in natural killer cells with a regulatory-compliant non-viral method.
    Li L; Liu LN; Feller S; Allen C; Shivakumar R; Fratantoni J; Wolfraim LA; Fujisaki H; Campana D; Chopas N; Dzekunov S; Peshwa M
    Cancer Gene Ther; 2010 Mar; 17(3):147-54. PubMed ID: 19745843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfection with mRNA for CD19 specific chimeric antigen receptor restores NK cell mediated killing of CLL cells.
    Boissel L; Betancur M; Wels WS; Tuncer H; Klingemann H
    Leuk Res; 2009 Sep; 33(9):1255-9. PubMed ID: 19147228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of mRNA and lentiviral based transfection of natural killer cells with chimeric antigen receptors recognizing lymphoid antigens.
    Boissel L; Betancur M; Lu W; Wels WS; Marino T; Van Etten RA; Klingemann H
    Leuk Lymphoma; 2012 May; 53(5):958-65. PubMed ID: 22023526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinically adaptable method to enhance the cytotoxicity of natural killer cells against B-cell malignancies.
    Shimasaki N; Fujisaki H; Cho D; Masselli M; Lockey T; Eldridge P; Leung W; Campana D
    Cytotherapy; 2012 Aug; 14(7):830-40. PubMed ID: 22458956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of hematopoietic stem/progenitor cells with CD19-specific chimeric antigen receptors as a novel approach for cancer immunotherapy.
    De Oliveira SN; Ryan C; Giannoni F; Hardee CL; Tremcinska I; Katebian B; Wherley J; Sahaghian A; Tu A; Grogan T; Elashoff D; Cooper LJ; Hollis RP; Kohn DB
    Hum Gene Ther; 2013 Oct; 24(10):824-39. PubMed ID: 23978226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient generation of gene-modified human natural killer cells via alpharetroviral vectors.
    Suerth JD; Morgan MA; Kloess S; Heckl D; Neudörfl C; Falk CS; Koehl U; Schambach A
    J Mol Med (Berl); 2016 Jan; 94(1):83-93. PubMed ID: 26300042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of Expanded NK Cells with Chimeric Antigen Receptor mRNA for Adoptive Cellular Therapy.
    Chu Y; Flower A; Cairo MS
    Methods Mol Biol; 2016; 1441():215-30. PubMed ID: 27177669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic and persistent effect of T-cell immunotherapy with anti-CD19 or anti-CD38 chimeric receptor in conjunction with rituximab on B-cell non-Hodgkin lymphoma.
    Mihara K; Yanagihara K; Takigahira M; Kitanaka A; Imai C; Bhattacharyya J; Kubo T; Takei Y; Yasunaga S; Takihara Y; Kimura A
    Br J Haematol; 2010 Oct; 151(1):37-46. PubMed ID: 20678160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mRNA Transfection to Improve NK Cell Homing to Tumors.
    Levy ER; Carlsten M; Childs RW
    Methods Mol Biol; 2016; 1441():231-40. PubMed ID: 27177670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-MHC-dependent redirected T cells against tumor cells.
    Almåsbak H; Lundby M; Rasmussen AM
    Methods Mol Biol; 2010; 629():453-93. PubMed ID: 20387166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphoma.
    Cooper LJ; Ausubel L; Gutierrez M; Stephan S; Shakeley R; Olivares S; Serrano LM; Burton L; Jensen MC; Forman SJ; DiGiusto DL
    Cytotherapy; 2006; 8(2):105-17. PubMed ID: 16698684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor associated antigen and interleukin-12 mRNA transfected dendritic cells enhance effector function of natural killer cells and antigen specific T-cells.
    Bontkes HJ; Kramer D; Ruizendaal JJ; Meijer CJ; Hooijberg E
    Clin Immunol; 2008 Jun; 127(3):375-84. PubMed ID: 18358784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonviral RNA transfection to transiently modify T cells with chimeric antigen receptors for adoptive therapy.
    Riet T; Holzinger A; Dörrie J; Schaft N; Schuler G; Abken H
    Methods Mol Biol; 2013; 969():187-201. PubMed ID: 23296935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programming human dendritic cells with mRNA.
    Lee J; Boczkowski D; Nair S
    Methods Mol Biol; 2013; 969():111-25. PubMed ID: 23296931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in vitro-transcribed-mRNA polyepitope construct encoding 32 distinct HLA class I-restricted epitopes from CMV, EBV, and Influenza for use as a functional control in human immune monitoring studies.
    Nielsen JS; Wick DA; Tran E; Nelson BH; Webb JR
    J Immunol Methods; 2010 Aug; 360(1-2):149-56. PubMed ID: 20637775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high throughput microelectroporation device to introduce a chimeric antigen receptor to redirect the specificity of human T cells.
    Choi Y; Yuen C; Maiti SN; Olivares S; Gibbons H; Huls H; Raphael R; Killian TC; Stark DJ; Lee DA; Torikai H; Monticello D; Kelly SS; Kebriaei P; Champlin RE; Biswal SL; Cooper LJ
    Biomed Microdevices; 2010 Oct; 12(5):855-63. PubMed ID: 20574820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid and efficient nonviral gene delivery of CD154 to primary chronic lymphocytic leukemia cells.
    Li LH; Biagi E; Allen C; Shivakumar R; Weiss JM; Feller S; Yvon E; Fratantoni JC; Liu LN
    Cancer Gene Ther; 2006 Feb; 13(2):215-24. PubMed ID: 16082377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells.
    Kowolik CM; Topp MS; Gonzalez S; Pfeiffer T; Olivares S; Gonzalez N; Smith DD; Forman SJ; Jensen MC; Cooper LJ
    Cancer Res; 2006 Nov; 66(22):10995-1004. PubMed ID: 17108138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced cytotoxicity of natural killer cells following the acquisition of chimeric antigen receptors through trogocytosis.
    Cho FN; Chang TH; Shu CW; Ko MC; Liao SK; Wu KH; Yu MS; Lin SJ; Hong YC; Chen CH; Hung CH; Chang YH
    PLoS One; 2014; 9(10):e109352. PubMed ID: 25313995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.